Revenue has certainly been disappointing to date but one point I will make regarding revenues is that I expect it will increase substantially this year (as a %) even if only the 2 deals remain in place.
The deal with Merck was signed 18 months ago, but was not expected to generate any material revenue in the short term. It was stated revenue would start to be generated in the medium-long term after a market had been established for the 2 new products that Merck was launching using Mix&Go. It was also stated that revenue forecasts would be given to Anteo starting in 2012 and updated on a yearly basis so we will definitely know more about the deal when the forecast is presented at some stage this year.
ADO Price at posting:
6.9¢ Sentiment: Buy Disclosure: Held
